Non-invasive first trimester blood test reliably detects Down's syndrome and other genetic fetal abnormalities
Friday, June 7, 2013 - 16:00
in Health & Medicine
New research has found that routine screening using a non-invasive test that analyzes fetal DNA in a pregnant woman's blood can accurately detect Down's syndrome and other genetic fetal abnormalities in the first trimester. The results suggest that the test is superior to currently available screening strategies and could reshape standards in prenatal testing.